A significant proportion of medicines are prescribed “off-label”. Targeting these cases will have detrimental treatment effects – medicine isn’t black and white. Scott Gottlieb writes:
It is true that some off-label drug use is based on very unsettled science and has more risks. But medicine “” and not just cancer care “” involves lots of hard choices.
Related posts:
- Did Medscape use CME to illegally promote off-label use of drugs for rheumatoid arthritis?
- The FDA tries to practice medicine
- Implications of the Arcoxia rejection
- Do drug companies and the pharma industry deserve to be villains?
- Medicare covers more cancer drugs, did they cave in to the pharmaceutical lobby?
- A woman dies after receiving 8 grams of Dilantin
- What if Elizabeth Edwards was in Europe?
KevinMD.com on Facebook
{ 1 comment }
I have yet to have a patient express any concern about off label uses. Which is too bad because some years ago I prepared exactly for that conversation. I collected a list of every drug useful during an anesthetic and noted the ages for on-label usage. Then I made a list for each age group of what was available, with the startling recognition that if your child is under 2 months, I’ve got nothing. Can’t even have bupivacaine local anesthetic until age 12. Toradol or opiates for pain, nope.
Comments on this entry are closed.